J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):121-123. Epub 2011 Sep 21.

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

Abstract

Cachexia, and particularly the loss of metabolically active lean tissue, leads to increased morbidity and mortality in affected patients. An impairment of strength and functional status is usually associated with cachexia. A variety of anabolic and appetite-stimulating agents have been studied in patients with cachexia caused by various underlying diseases. Overall, these studies have demonstrated that treatment can increase body weight and/or lean body mass. However, these therapies may have severe side effects, particularly when utilizing testosterone and related anabolic steroids targeting the androgen receptor. These side effects include cardiovascular problems, prostate hyperplasia and cancer in men, as well as virilization in women.

PMID:: 21966638; [PubMed]
PMCID:: PMC3177042

Free PMC Article

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. [Future Oncol. 2009]
Review Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.
Zilbermint MF, Dobs AS. Future Oncol. 2009 Oct; 5(8):1211-20.
Review Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. [Int J Cardiol. 2002]
Review Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.
Mulligan K, Schambelan M. Int J Cardiol. 2002 Sep; 85(1):151-9.
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. [J Cachexia Sarcopenia Muscle. ...]
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.
Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS. J Cachexia Sarcopenia Muscle. 2011 Sep; 2(3):153-161. Epub 2011 Aug 2.
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. [J Clin Endocrinol Metab. 1996]
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, et al. J Clin Endocrinol Metab. 1996 Nov; 81(11):4051-8.
The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. [J Gerontol A Biol Sci Med Sci....]
The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men.
Basaria S, Collins L, Dillon EL, Orwoll K, Storer TW, Miciek R, Ulloor J, Zhang A, Eder R, Zientek H, et al. J Gerontol A Biol Sci Med Sci. 2012 Mar 28; . Epub 2012 Mar 28.

See reviews... See all...

Cited by 1 PubMed Central article

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference. [J Cachexia Sarcopenia Muscle. ...]
Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.
Ebner N, Werner CG, Doehner W, Anker SD, von Haehling S. J Cachexia Sarcopenia Muscle. 2012 Mar; 3:45-50. Epub 2012 Mar 2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Breakthrough in cachexia treatment through a novel selective androgen receptor m...
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):121-123. Epub 2011 Sep 21.

PubMed
[Disorders of voluntary motor activity and lesions of caudate nuclei].
[Disorders of voluntary motor activity and lesions of caudate nuclei].
Rev Neurol (Paris). 1990 ;146(5):338-44.

PubMed
Phase resetting of the mammalian circadian clock relies on a rapid shift of a sm...
Phase resetting of the mammalian circadian clock relies on a rapid shift of a small population of pacemaker neurons.
PLoS One. 2011 ;6(9):e25437. Epub 2011 Sep 22 .

PubMed
Double-blind placebo-controlled study of nortriptyline in depressed adolescents ...
Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.
Psychopharmacol Bull. 1990 ;26(1):85-90.

PubMed
Meningococcal purpura fulminans in children. II: Late orthopedic sequelae manage...
Meningococcal purpura fulminans in children. II: Late orthopedic sequelae management.
J Child Orthop. 2010 Oct ;4(5):409-16. Epub 2010 Aug 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

Abstract

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information